MICA Biosystems
Birmingham · Founded 2010
About MICA Biosystems
MICAs novel patented technology utilises magnetic nanoparticles to control cell behaviour inside and outside the body using custom designed and built magnetic arrays. Using this technology we have established a novel dynamic drug screening assay, DYNASCREEN. Further stem cell therapy applications have been explored with ambitions of clinical adoption for the treatment of bone and cartilage injuries. MICA scientists are experienced in functionalising magnetic nanoparticles with any antibody, peptide or small molecule to suit a range of applications.
Company Facts
- Founded: 2010
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.1M
- Funding stage: Seed
- Last round: Grant (Dec 2021)
- Website: https://www.micabiosystems.co.uk/
- Phone: +44 (0)1782 674 085
Industries & Categories
Biotechnology, Health Care, Life Science, Medical Device, Nanotechnology
Social Profiles
Canonical: https://fsome.com/organization/mica-biosystems-155812 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.